Graph self-supervised learning (GSL) is essential for processing graph-structured data, reducing the need for manual labeling. Traditionally, this paradigm has extensively utilized Bayesian Personalized Ranking (BPR) as its primary loss function. Despite its widespread application, the theoretical analysis of its node relations evaluation have remained largely unexplored. This paper employs recent advancements in latent hyperbolic geometry to deepen our understanding of node relationships from a graph-theoretical perspective. We analyze BPR's limitations, particularly its reliance on local connectivity through 2-hop paths, which overlooks global connectivity and the broader topological structure.

I'd Rather Risk Cancer Than See AI Move This Fast I'd benefit if AI cured cancer. And I still want AI progress to slow down. On a fall afternoon 15 years ago, I met an idealistic researcher outside a Stanford coffee shop to discuss our shared dream: using AI to detect cancer. He had wiry hair, a penchant for talking with his hands, and a reputation for brilliance. He worked at a research lab that developed early screens for cancer; I, at 20, had just learned that I carried a mutation that conferred a very high risk of breast, ovarian, and other cancers.

Former US Attorney General Pam Bondi, who was removed from her role last month, has been diagnosed with thyroid cancer, according to multiple US outlets. Her diagnosis came shortly after President Donald Trump ousted her from the post of America's top law enforcement officer, according to Axios, which first reported the news of her illness. Bondi, 60, told CNN she is undergoing treatment and is still recovering from surgery that took place a few weeks ago, but is doing well. She is continuing to work despite the diagnosis, and will be joining the White House's new advisory council on AI, the Presidential Council of Advisors on Science and Technology. Podcast host and former White House adviser Katie Miller posted on social media that Pam has been quietly kicking cancer's ass the last few weeks, adding that Bondi has a heart of gold.

CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for managing HIV. A Miracle cancer therapy that involves engineering a patient's own immune cells is being repurposed for HIV, and early results from two individuals hint at its promise for long-term control of the virus. As part of a clinical trial, scientists took people's own immune cells and reprogrammed them in a lab to recognize and attack HIV in the body. After a single infusion of the modified cells, two individuals with HIV now have undetectable levels of the virus--one for nearly two years and the other for almost a year.

This material may not be published, broadcast, rewritten, or redistributed. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset . Powered and implemented by FactSet Digital Solutions . Mutual Fund and ETF data provided by LSEG . Apple's $250M Siri settlement: Are you owed cash?

A team of scientists from Nanyang Technological University Singapore has developed a new biochip that, when paired with computer vision, can detect quickly and accurately extremely small amounts of microRNAs, which are tiny genetic markers linked to diseases such as heart disease. Published in the scientific journal, the new biosensing platform combines a specially designed nanophotonic chip with AI-automated image analysis. With a tiny drop of blood loaded into the chip, it can rapidly detect multiple microRNA biomarkers. With its integrated AI imaging function, thousands of microRNA signals can be imaged and analysed in a single snapshot. Compared with the current gold standard of detecting microRNA - PCR (polymerase chain reaction) detects tiny amounts of genetic material by copying them many times - the new device can cut detection time from hours to 20 minutes. MicroRNAs are short RNA molecules that help regulate genes that work in the body.

Be careful asking chatbots about your health. After George Mallon had his blood drawn at a routine physical, he learned that something may be gravely wrong. The preliminary results showed he might have blood cancer. Further tests would be needed. Left in suspense, he did what so many people do these days: He opened ChatGPT.

Precision medicine aims for personalized prognosis and therapeutics by utilizing recent genome-scale high-throughput profiling techniques, including next-generation sequencing (NGS). However, translating NGS data faces several challenges. First, NGS count data are often overdispersed, requiring appropriate modeling. Second, compared to the number of involved molecules and system complexity, the number of available samples for studying complex disease, such as cancer, is often limited, especially considering disease heterogeneity. The key question is whether we may integrate available data from all different sources or domains to achieve reproducible disease prognosis based on NGS count data. In this paper, we develop a Bayesian Multi-Domain Learning (BMDL) model that derives domain-dependent latent representations of overdispersed count data based on hierarchical negative binomial factorization for accurate cancer subtyping even if the number of samples for a specific cancer type is small. Experimental results from both our simulated and NGS datasets from The Cancer Genome Atlas (TCGA) demonstrate the promising potential of BMDL for effective multi-domain learning without ``negative transfer'' effects often seen in existing multi-task learning and transfer learning methods.

Kentucky mother and daughter turn down $26.5MILLION to sell their farms to secretive tech giant that wants to build data center there Horrifying next twist in the Alexander brothers case: MAUREEN CALLAHAN exposes an unthinkable perversion that's been hiding in plain sight Hollywood icon who starred in Psycho after Hitchcock dubbed her'my new Grace Kelly' looks incredible at 95 Kylie Jenner's total humiliation in Hollywood: Derogatory rumor leaves her boyfriend's peers'laughing at her' behind her back Tucker Carlson erupts at Trump adviser as she hurls'SLANDER' claim linking him to synagogue shooting Ben Affleck'scores $600m deal' with Netflix to sell his AI film start-up Long hair over 45 is ageing and try-hard. I've finally cut mine off. Alexander brothers' alleged HIGH SCHOOL rape video: Classmates speak out on sickening footage... as creepy unseen photos are exposed Heartbreaking video shows very elderly DoorDash driver shuffle down customer's driveway with coffee order because he is too poor to retire Amber Valletta, 52, was a '90s Vogue model who made movies with Sandra Bullock and Kate Hudson, see her now Model Cindy Crawford, 60, mocked for her'out of touch' morning routine: 'Nothing about this is normal' A US patent for a potential breakthrough cancer treatment is drawing renewed attention after declassified CIA documents revealed how scientists may have been close to a cure 60 years ago. The patent, published by Johns Hopkins University in 2021 and titled'Mebendazole Polymorph for Treatment and Prevention of Tumors,' outlines how specific formulations of the drug mebendazole may be used to target cancer cells. Mebendazole has been used safely for more than four decades to treat parasitic worm infections in humans, but researchers have increasingly investigated whether the drug could also help fight certain cancers, including aggressive brain tumors.